CDLX Quote, Financials, Valuation and Earnings

Lendway has a net margin of -216.51% compared to Cardlytics's net margin of -16.97%. Cardlytics's return on equity of -163.62% beat Lendway's return on equity of -20.1%.

Cardlytics has a consensus price target of --, signalling upside risk potential of 13.7%. On the other hand Lendway has an analysts' consensus of -- which suggests that it could fall by --. Given that Cardlytics has higher upside potential than Lendway, analysts believe Cardlytics is more attractive than Lendway.

Cardlytics has a beta of 1.531, which suggesting that the stock is 53.072% more volatile than S&P 500. In comparison Lendway has a beta of 1.897, suggesting its more volatile than the S&P 500 by 89.693%.

Cardlytics has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lendway offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardlytics pays -- of its earnings as a dividend. Lendway pays out -- of its earnings as a dividend.

Cardlytics quarterly revenues are $67.1M, which are larger than Lendway quarterly revenues of $6.6M. Cardlytics's net income of -$145.2M is lower than Lendway's net income of -$1.1M. Notably, Cardlytics's price-to-earnings ratio is -- while Lendway's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardlytics is 0.60x versus -- for Lendway. Usually stocks with elevated PS ratios are considered overvalued.

Magnite has a net margin of -216.51% compared to Cardlytics's net margin of 3.22%. Cardlytics's return on equity of -163.62% beat Magnite's return on equity of 2.48%.

Cardlytics has a consensus price target of --, signalling upside risk potential of 13.7%. On the other hand Magnite has an analysts' consensus of $18.42 which suggests that it could grow by 12.2%. Given that Cardlytics has higher upside potential than Magnite, analysts believe Cardlytics is more attractive than Magnite.

Cardlytics has a beta of 1.531, which suggesting that the stock is 53.072% more volatile than S&P 500. In comparison Magnite has a beta of 2.505, suggesting its more volatile than the S&P 500 by 150.466%.

Cardlytics has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Magnite offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardlytics pays -- of its earnings as a dividend. Magnite pays out -- of its earnings as a dividend.

Cardlytics quarterly revenues are $67.1M, which are smaller than Magnite quarterly revenues of $162M. Cardlytics's net income of -$145.2M is lower than Magnite's net income of $5.2M. Notably, Cardlytics's price-to-earnings ratio is -- while Magnite's PE ratio is 273.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardlytics is 0.60x versus 3.52x for Magnite. Usually stocks with elevated PS ratios are considered overvalued.

Travelzoo has a net margin of -216.51% compared to Cardlytics's net margin of 15.84%. Cardlytics's return on equity of -163.62% beat Travelzoo's return on equity of 216.03%.

Cardlytics has a consensus price target of --, signalling upside risk potential of 13.7%. On the other hand Travelzoo has an analysts' consensus of $16.00 which suggests that it could grow by 20.25%. Given that Travelzoo has higher upside potential than Cardlytics, analysts believe Travelzoo is more attractive than Cardlytics.

Cardlytics has a beta of 1.531, which suggesting that the stock is 53.072% more volatile than S&P 500. In comparison Travelzoo has a beta of 1.712, suggesting its more volatile than the S&P 500 by 71.219%.

Cardlytics has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Travelzoo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardlytics pays -- of its earnings as a dividend. Travelzoo pays out -- of its earnings as a dividend.

Cardlytics quarterly revenues are $67.1M, which are larger than Travelzoo quarterly revenues of $20.1M. Cardlytics's net income of -$145.2M is lower than Travelzoo's net income of $3.2M. Notably, Cardlytics's price-to-earnings ratio is -- while Travelzoo's PE ratio is 19.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardlytics is 0.60x versus 3.26x for Travelzoo. Usually stocks with elevated PS ratios are considered overvalued.

Ziff Davis has a net margin of -216.51% compared to Cardlytics's net margin of -13.74%. Cardlytics's return on equity of -163.62% beat Ziff Davis's return on equity of 3.38%.

Cardlytics has a consensus price target of --, signalling upside risk potential of 13.7%. On the other hand Ziff Davis has an analysts' consensus of -- which suggests that it could grow by 30.29%. Given that Ziff Davis has higher upside potential than Cardlytics, analysts believe Ziff Davis is more attractive than Cardlytics.

Cardlytics has a beta of 1.531, which suggesting that the stock is 53.072% more volatile than S&P 500. In comparison Ziff Davis has a beta of 1.348, suggesting its more volatile than the S&P 500 by 34.842%.

Cardlytics has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ziff Davis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cardlytics pays -- of its earnings as a dividend. Ziff Davis pays out -- of its earnings as a dividend.

Cardlytics quarterly revenues are $67.1M, which are smaller than Ziff Davis quarterly revenues of $353.6M. Cardlytics's net income of -$145.2M is lower than Ziff Davis's net income of -$48.6M. Notably, Cardlytics's price-to-earnings ratio is -- while Ziff Davis's PE ratio is 47.76x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cardlytics is 0.60x versus 1.91x for Ziff Davis. Usually stocks with elevated PS ratios are considered overvalued.